Yayın:
Canonical NF-κB p65, but Not p105, Contributes to IL-1β-Induced IL-8 Expression in Cardiac Fibroblasts

dc.contributor.authorMizuno, Masashi
dc.contributor.authorNakano, Rei
dc.contributor.authorNakano, Rei
dc.contributor.authorNakano, Rei
dc.contributor.authorNose, Saki
dc.contributor.authorMatsumura, Moeka
dc.contributor.authorNii, Yasuyuki
dc.contributor.authorKurogochi, Kentaro
dc.contributor.authorSugiya, Hiroshi
dc.contributor.authorUechi, Masami
dc.date.accessioned2026-01-25T03:42:51Z
dc.date.issued2022-04-20
dc.description.abstractCardiac fibroblasts participate in the inflammatory process of heart diseases as sentinel cells of the cardiac tissue. In this study, we investigated the effect of the proinflammatory cytokine, interleukin 1β (IL-1β), on the expression of interleukin 8 (IL-8), which contributes to the induction of innate immunityviathe activation and recruitment of innate immune cells, such as neutrophils, to the site of inflammation in canine cardiac fibroblasts. IL-1β mediates IL-8 mRNA expression and protein release in a dose- and time-dependent manner. The IL-β-mediated IL-8 protein release and mRNA expression were inhibited by 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide, an inhibitor of the transcription factor, nuclear factor (NF)-κB. In cells treated with IL-1β, NF-κB p65 and p105 were transiently phosphorylated, indicating the activation of NF-κB. However, IL-1β failed to induce IL-8 mRNA expression in the cells transfected with p65 small interfering RNA (siRNA), but not in those transfected with p105 siRNA. These observations suggest that IL-1β induces IL-8 expressionviathe activation of NF-κB p65 in canine cardiac fibroblasts.
dc.description.urihttps://doi.org/10.3389/fimmu.2022.863309
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/35514973
dc.description.urihttp://dx.doi.org/10.3389/fimmu.2022.863309
dc.description.urihttps://doaj.org/article/a45d4f0cefd249cba09f35fdc18aa44d
dc.identifier.doi10.3389/fimmu.2022.863309
dc.identifier.eissn1664-3224
dc.identifier.openairedoi_dedup___::58c8f4da161063918bd27b164f226785
dc.identifier.orcid0000-0003-0255-6347
dc.identifier.orcid0009-0000-6324-6268
dc.identifier.orcid0000-0002-1206-7769
dc.identifier.urihttps://hdl.handle.net/11527/44280
dc.identifier.volume13
dc.publisherFrontiers Media SA
dc.relation.ispartofFrontiers in Immunology
dc.rightsOPEN
dc.sdg.typeGoal 3: Good Health and Well-being
dc.subjectImmunology
dc.subjectInterleukin-1beta
dc.subjectInterleukin-8
dc.subjectNF-kappa B
dc.subjectinterleukin 8
dc.subjectRC581-607
dc.subjectFibroblasts
dc.subjectDogs
dc.subjectinflammation
dc.subjectAnimals
dc.subjectinterleukin 1β
dc.subjectNF-κB p65
dc.subjectRNA, Messenger
dc.subjectImmunologic diseases. Allergy
dc.subjectRNA, Small Interfering
dc.subjectcardiac fibroblasts
dc.titleCanonical NF-κB p65, but Not p105, Contributes to IL-1β-Induced IL-8 Expression in Cardiac Fibroblasts
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyonlar